` MX1 (Micro-X Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

MX1
vs
S
S&P/ASX 300

Over the past 12 months, MX1 has outperformed S&P/ASX 300, delivering a return of +14% compared to the S&P/ASX 300's +4% growth.

Stocks Performance
MX1 vs S&P/ASX 300

Loading
MX1
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MX1 vs S&P/ASX 300

Loading
MX1
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
MX1 vs S&P/ASX 300

Loading
MX1
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Micro-X Ltd vs Peers

S&P/ASX 300
MX1
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Micro-X Ltd
Glance View

Market Cap
53.4m AUD
Industry
Health Care

Micro-X Ltd. manufactures, designs, and develops ultra-lightweight carbon nanotube based X-ray products for the global healthcare and explosive device markets. The company is headquartered in Adelaide, South Australia. The company went IPO on 2015-12-22. The firm provides medical and security imaging products using cold cathode X-ray sources. The Company’s X-ray products include mobile digital X-ray machines, intermittent explosive disorder (IED) X-ray camera, miniature baggage scanner and computed tomography (CT) brain scanner. The Electronic X-Ray Tube is the foundation of its product development and innovation. The Company’s lead patented carbon nanotube technology ensures its products are lighter, smaller and more portable than traditional X-ray devices. The technology also develops X-ray imaging across the medical, defense, security screening and veterinary industries.

MX1 Intrinsic Value
0.11 AUD
Undervaluation 27%
Intrinsic Value
Price
Back to Top